FDG PET/CT outperforms biopsy for detection of malignancy in lymphoma

May 16, 2013

The gold standard for the detection of bone marrow invasion of diffuse large B-cell lymphoma (DBLCL) is bone marrow biopsy (BMB). Researchers investigated a new approach with F-18 FDG PET/CT imaging to determine its efficacy and predictive value. The latter was found superior to biopsy in not only its sensitivity and accuracy, but also its ability to predict progression-free survival, according to a study published online May 14 in the Journal of Nuclear Medicine.